Pharmacokinetic profile of diazepam in man following single intravenous and oral and chronic oral administrations. 1973

S A Kaplan, and M L Jack, and K Alexander, and R E Weinfeld

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D003975 Diazepam A benzodiazepine with anticonvulsant, anxiolytic, sedative, muscle relaxant, and amnesic properties and a long duration of action. Its actions are mediated by enhancement of GAMMA-AMINOBUTYRIC ACID activity. 7-Chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one,Apaurin,Diazemuls,Faustan,Relanium,Seduxen,Sibazon,Stesolid,Valium
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001711 Biotransformation The chemical alteration of an exogenous substance by or in a biological system. The alteration may inactivate the compound or it may result in the production of an active metabolite of an inactive parent compound. The alterations may be divided into METABOLIC DETOXICATION, PHASE I and METABOLIC DETOXICATION, PHASE II.

Related Publications

S A Kaplan, and M L Jack, and K Alexander, and R E Weinfeld
January 1982, Arzneimittel-Forschung,
S A Kaplan, and M L Jack, and K Alexander, and R E Weinfeld
May 1972, Journal of pharmaceutical sciences,
S A Kaplan, and M L Jack, and K Alexander, and R E Weinfeld
January 1998, European journal of drug metabolism and pharmacokinetics,
S A Kaplan, and M L Jack, and K Alexander, and R E Weinfeld
May 2006, Planta medica,
S A Kaplan, and M L Jack, and K Alexander, and R E Weinfeld
January 2022, Journal of veterinary pharmacology and therapeutics,
S A Kaplan, and M L Jack, and K Alexander, and R E Weinfeld
May 1988, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
S A Kaplan, and M L Jack, and K Alexander, and R E Weinfeld
January 1998, European journal of drug metabolism and pharmacokinetics,
S A Kaplan, and M L Jack, and K Alexander, and R E Weinfeld
November 2023, Journal of veterinary pharmacology and therapeutics,
Copied contents to your clipboard!